277 related articles for article (PubMed ID: 11845304)
1. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
Shori DK; Genter T; Hansen J; Koch C; Wyatt H; Kariyawasam HH; Knight RA; Hodson ME; Kalogeridis A; Tsanakas I
Pflugers Arch; 2001; 443 Suppl 1():S55-61. PubMed ID: 11845304
[TBL] [Abstract][Full Text] [Related]
2. Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis.
Shori DK; Kariyawasam HH; Knight RA; Hodson ME; Genter T; Hansen J; Koch C; Kalogeridis A
Pflugers Arch; 2001; 443 Suppl 1():S50-4. PubMed ID: 11845303
[TBL] [Abstract][Full Text] [Related]
3. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis.
Xia B; Royall JA; Damera G; Sachdev GP; Cummings RD
Glycobiology; 2005 Aug; 15(8):747-75. PubMed ID: 15994837
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation of sputum mucins is altered in cystic fibrosis patients.
Schulz BL; Sloane AJ; Robinson LJ; Prasad SS; Lindner RA; Robinson M; Bye PT; Nielson DW; Harry JL; Packer NH; Karlsson NG
Glycobiology; 2007 Jul; 17(7):698-712. PubMed ID: 17392389
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
[TBL] [Abstract][Full Text] [Related]
6. MUC5B glycosylation in human saliva reflects blood group and secretor status.
Thomsson KA; Schulz BL; Packer NH; Karlsson NG
Glycobiology; 2005 Aug; 15(8):791-804. PubMed ID: 15814823
[TBL] [Abstract][Full Text] [Related]
7. Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x.
Karlsson NG; Thomsson KA
Glycobiology; 2009 Mar; 19(3):288-300. PubMed ID: 19043084
[TBL] [Abstract][Full Text] [Related]
8. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.
Schulz BL; Sloane AJ; Robinson LJ; Sebastian LT; Glanville AR; Song Y; Verkman AS; Harry JL; Packer NH; Karlsson NG
Biochem J; 2005 May; 387(Pt 3):911-9. PubMed ID: 15563276
[TBL] [Abstract][Full Text] [Related]
9. Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori.
Prakobphol A; Borén T; Ma W; Zhixiang P; Fisher SJ
Biochemistry; 2005 Feb; 44(6):2216-24. PubMed ID: 15697247
[TBL] [Abstract][Full Text] [Related]
10. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.
Davies JR; Svitacheva N; Lannefors L; Kornfält R; Carlstedt I
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):321-30. PubMed ID: 10567212
[TBL] [Abstract][Full Text] [Related]
11. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
Henke MO; John G; Germann M; Lindemann H; Rubin BK
Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
[TBL] [Abstract][Full Text] [Related]
12. Salivary gel-forming mucin MUC5B--a nutrient for dental plaque bacteria.
Wickström C; Svensäter G
Oral Microbiol Immunol; 2008 Jun; 23(3):177-82. PubMed ID: 18402602
[TBL] [Abstract][Full Text] [Related]
13. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
Carnoy C; Ramphal R; Scharfman A; Lo-Guidice JM; Houdret N; Klein A; Galabert C; Lamblin G; Roussel P
Am J Respir Cell Mol Biol; 1993 Sep; 9(3):323-34. PubMed ID: 8398170
[TBL] [Abstract][Full Text] [Related]
14.
Chahal G; Quintana-Hayashi MP; Gaytán MO; Benktander J; Padra M; King SJ; Linden SK
Front Cell Infect Microbiol; 2022; 12():889711. PubMed ID: 35782137
[No Abstract] [Full Text] [Related]
15. Carbocisteine normalizes the viscous property of mucus through regulation of fucosylated and sialylated sugar chain on airway mucins.
Ishibashi Y; Takayama G; Inouye Y; Taniguchi A
Eur J Pharmacol; 2010 Sep; 641(2-3):226-8. PubMed ID: 20553908
[TBL] [Abstract][Full Text] [Related]
16. Structure and biosynthesis of human salivary mucins.
Zalewska A; Zwierz K; Zółkowski K; Gindzieński A
Acta Biochim Pol; 2000; 47(4):1067-79. PubMed ID: 11996097
[TBL] [Abstract][Full Text] [Related]
17. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression.
Hanski C; Drechsler K; Hanisch FG; Sheehan J; Manske M; Ogorek D; Klussmann E; Hanski ML; Blank M; Xing PX
Cancer Res; 1993 Sep; 53(17):4082-8. PubMed ID: 7689422
[TBL] [Abstract][Full Text] [Related]
18. Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.
Lamblin G; Degroote S; Perini JM; Delmotte P; Scharfman A; Davril M; Lo-Guidice JM; Houdret N; Dumur V; Klein A; Rousse P
Glycoconj J; 2001 Sep; 18(9):661-84. PubMed ID: 12386453
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa pyocyanin modulates mucin glycosylation with sialyl-Lewis(x) to increase binding to airway epithelial cells.
Jeffries JL; Jia J; Choi W; Choe S; Miao J; Xu Y; Powell R; Lin J; Kuang Z; Gaskins HR; Lau GW
Mucosal Immunol; 2016 Jul; 9(4):1039-1050. PubMed ID: 26555707
[TBL] [Abstract][Full Text] [Related]
20. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa.
Martínez-Antón A; Debolós C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J
Clin Exp Allergy; 2006 Apr; 36(4):448-57. PubMed ID: 16630149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
